Tevogen Bio Holdings (TVGN) Shares Outstanding (Weighted Average) (2021 - 2026)

Tevogen Bio Holdings has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $17.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 438.59% year-over-year to $17.4 million; the trailing twelve-month figure through Mar 2026 stood at $17.4 million (up 438.59% YoY), and the FY2025 full-year result was $3.3 million, up 13.17% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $17.4 million, up from $3.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $196.0 million in Q3 2025, with the low at $1.4 million in Q4 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $79.7 million across 5 years, with a median of $35.9 million in 2022.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) jumped 1607.03% — and 2025, when it tumbled 97.65%.
• Tevogen Bio Holdings' Shares Outstanding (Weighted Average) stood at $1.4 million in 2022, then jumped by 1607.03% to $24.8 million in 2023, then plunged by 88.15% to $2.9 million in 2024, then gained by 13.17% to $3.3 million in 2025, then jumped by 423.72% to $17.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $17.4 million (Q1 2026), $3.3 million (Q4 2025), and $196.0 million (Q3 2025), per Business Quant data.